Loading...
Bioventus Inc.
BVS•NASDAQ
Healthcare
Medical - Devices
$6.57
$0.17(2.66%)
Bioventus Inc. (BVS) Financial Performance & Income Statement Overview
Review Bioventus Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
11.89%
↑ 11.89%
Operating Income Growth
85.34%
↑ 85.34%
Net Income Growth
78.53%
↑ 78.53%
Operating Cash Flow Growth
152.83%
↑ 152.83%
Operating Margin
-2.19%
↓ 2.19%
Gross Margin
67.14%
↑ 67.14%
Net Profit Margin
-5.57%
↓ 5.57%
ROE
-21.22%
↓ 21.22%
ROIC
-2.41%
↓ 2.41%
Bioventus Inc. (BVS) Income Statement & Financial Overview
Review Bioventus Inc.'s (BVS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $153.64M | $138.96M | $151.22M | $129.46M |
| Cost of Revenue | $50.99M | $45.41M | $47.58M | $41.08M |
| Gross Profit | $102.66M | $93.55M | $103.64M | $88.38M |
| Gross Profit Ratio | $0.67 | $0.67 | $0.69 | $0.68 |
| R&D Expenses | $3.25M | $3.81M | $3.99M | $2.60M |
| SG&A Expenses | $86.61M | $81.09M | $94.78M | $78.41M |
| Operating Expenses | $94.67M | $84.90M | $133.007M | $83.05M |
| Total Costs & Expenses | $140.84M | $130.31M | $180.59M | $124.13M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $9.00M | $9.53M | $9.92M | $10.34M |
| Depreciation & Amortization | $12.40M | $12.28M | $13.09M | $11.79M |
| EBITDA | $21.63M | $16.98M | -$16.44M | $17.05M |
| EBITDA Ratio | $0.14 | $0.12 | -$0.11 | $0.13 |
| Operating Income | $7.99M | $4.07M | -$29.37M | $5.33M |
| Operating Income Ratio | $0.05 | $0.03 | -$0.19 | $0.04 |
| Other Income/Expenses (Net) | -$7.76M | -$8.91M | -$10.08M | -$10.40M |
| Income Before Tax | $232000.00 | -$4.83M | -$39.45M | -$5.08M |
| Income Before Tax Ratio | $0.002 | -$0.03 | -$0.26 | -$0.04 |
| Income Tax Expense | $550000.00 | $589000.00 | -$7.34M | $907000.00 |
| Net Income | -$156000.00 | -$4.82M | -$23.99M | -$4.57M |
| Net Income Ratio | -$0.001 | -$0.03 | -$0.16 | -$0.04 |
| EPS | -$0.002 | -$0.07 | -$0.37 | -$0.07 |
| Diluted EPS | -$0.002 | -$0.07 | -$0.37 | -$0.07 |
| Weighted Avg Shares Outstanding | $65.45M | $65.26M | $64.06M | $63.38M |
| Weighted Avg Shares Outstanding (Diluted) | $65.45M | $65.26M | $64.06M | $63.38M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan